(Q41016807)

25 September 2017

title

The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer (English)

1 reference

25 September 2017

1 reference

Qinghua Xi

1

1 reference

25 September 2017

Menghui Huang

2

1 reference

25 September 2017

Yingying Wang

3

1 reference

25 September 2017

Jianxin Zhong

4

1 reference

25 September 2017

Rong Liu

5

1 reference

25 September 2017

Guiqin Xu

6

1 reference

25 September 2017

Lifei Jiang

7

1 reference

25 September 2017

Juan Wang

8

1 reference

25 September 2017

Zheng Fang

9

1 reference

25 September 2017

Shuyun Yang

10

1 reference

25 September 2017

publication date

25 April 2015

1 reference

25 September 2017

1 reference

25 September 2017

volume

36

1 reference

25 September 2017

issue

7

1 reference

25 September 2017

page(s)

4939-4948

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3141-8

25 September 2017

exact match

0 references

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Treatment options in recurrent ovarian cancer: latest evidence and clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Physiological relevance of cell cycle kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Growth and division--not a one-way road

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Cell cycle, CDKs and cancer: a changing paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Sulforaphane induced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/CDC2 in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Millepachine, a novel chalcone, induces G2/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

CDK1 interacts with RARγ and plays an important role in treatment response of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3141-8

The clinical significance of CDK1 expression in oral squamous cell carcinoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25910705

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CDK2 and CDK4 play important roles in promoting the proliferation of SKOV3 ovarian carcinoma cells induced by tumor-associated macrophages

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25910705

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-015-3141-8

1 reference

Dimensions Publication ID

25 September 2017

1008123915

0 references

1 reference